The Role of Genetic Variants in Rheumatoid Arthritis Pathophysiology and their Impact on Disease Mechanisms
DOI:
https://doi.org/10.31584/jhsmr.20241061Keywords:
genetic variants, pathogenesis, pathways, rheumatoid arthritisAbstract
Rheumatoid arthritis (RA) is a chronic inflammatory condition caused by genetic and environmental factors. By identifying genomic regions associated with an increased risk of RA, Genome-wide association study (GWAS) has provided insight into the genetic component of the condition. A better understanding of these characteristics is necessary to improve RA therapy. The objective is to identify gene variants associated with RA susceptibility, severity, and progression. A search of PubMed, Embase, Scopus, Science Direct, and MEDLINE databases revealed articles concerning rheumatoid arthritis, genetics, genetic aspects, and autoimmune disorders. The research studies considered were reviews, meta-analyses, randomized controlled trials, and systematic reviews. The data was sought from May 2016 and May 2023. Genetic factors are thought to play a significant role in the production of cytokines, the activity of immune cells, and abnormal immune responses in RA. By combining molecular genetics with clinical characteristics, it is possible to enhance RA medications and provide tailored care to each individual. Recent studies have identified several susceptibility loci and key genes associated with the development of RA, providing insight into the mechanism underlying the disease. These genetic associations can be used to develop targeted medicines and personalized care strategies for people whom have rheumatoid arthritis. The purpose of this review is to enhance the quality of life by finding the gene mechanism of patients suffering from RAl; however, more research is still required to understand genetic and environmental influences fully.
References
Janakiraman V, Sudhan M, Patil S, Alzahrani KJ, Alzahrani FM, Halawani IF et al. Rheumatoid arthritis treatment with zoledronic acid, a potential inhibitor of GWAS-derived pharmacogenetics STAT3 and IL2 targets. Gene 2023 May 25;866:147338.
Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int 2021;41:863-77.
Choi ST, Lee KH. Clinical management of seronegative and seropositive rheumatoid arthritis: a comparative study. PLoS One 2018;13:e0195550.
Ma L, Cranney A, Holroyd-Leduc JM. Acute monoarthritis: What is the cause of my patient's painful swollen joint? CMAJ 2009;180:59-65.
McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19.
Dadonienė J, Charukevič G, Jasionytė G, Staškuvienė K, Miltinienė D. Mortality in inflammatory rheumatic diseases: Lithuanian national registry data and systematic review. Int J Environ Res Public Health 2021;18:12338.
Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR. Firestein and Kelley's Textbook of Rheumatology. In:
Koretzky G, editor. Philadelphia: Elsevier; 2017.
Hannon E, Weedon M, Bray N, O’Donovan M, Mill J. Pleiotropic effects of trait-associated genetic variation on DNA methylation: utility for refining GWAS loci. Am J Hum Genet 2017;100:954-9.
Houtman M, Shchetynsky K, Chemin K, Hensvold AH, Ramsköld D, Tandre K, et al. T cells are influenced by a long non-coding RNA in the autoimmune associated PTPN2 locus. J Autoimmun 2018;90:28-38.
Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014;506:376–81.
Ha E, Bae SC, Kim K. Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci. Ann Rheum Dis 2021;80:558–65.
Ishigaki K, Sakaue S, Terao C, Luo Y, Sonehara K, Yamaguchi K, et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat Genet 2022;54:1640-51.
Padyukov L. Genetics of rheumatoid arthritis. Semin Immunopathol 2022;44:47-62.
Akhtar M, Jamal T, Jamal H, Din JU, Jamal M, Arif M, et al. Identification of most damaging nsSNPs in human CCR6 gene: In silico analyses. Int J Immunogenet 2019;46:459-71.
Jahid M, Chawla D, Avasthi R, Ahmed RS. Association of polymorphic variants in IL1B gene with secretion of IL-1β protein and inflammatory markers in north Indian rheumatoid arthritis patients. Gene 2018;30:641:63-7.
Cheng T, Sun X, Wu J, Wang M, Eisenberg RA, Chen Z. Increased serum levels of tumor necrosis factor receptor-associated factor 1 (TRAF1) correlate with disease activity and autoantibodies in rheumatoid arthritis. Clinica Chimica Acta 2016;1;462:103-6.
Abbasifard M, Imani D, Bagheri-Hosseinabadi Z. PTPN22 gene polymorphism and susceptibility to RA: updated systematic review and meta-analysis. J Gene Med 2020;22:e3204.
Yang J, McGovern A, Martin P, Duffus K, Ge X, Zarrineh P, et al. Analysis of chromatin organization and gene expression in T cells identifies functional genes for rheumatoid arthritis. Nat Commun 2020;11:4402.
Yap HY, Tee SZ, Wong MM, Chow SK, Peh SC, Teow SY, et al. Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development. Cells 2018;7:161.
Wang H, Chen W, Wang L, Li F, Zhang C, Xu L. Tumor necrosis factor receptor-associated factor 6 promotes migration of rheumatoid arthritis fibroblast-like synoviocytes. Mol Med Rep 2015;11:2761-6.
Bombardieri M, Lewis M, Pitzalis C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat Rev Rheumatol 2017;13:141-54.
Floudas A, Neto N, Marzaioli V, Murray K, Moran B, Monaghan MG, et al. Pathogenic, glycolytic PD-1+ B-cells accumulate in the hypoxic RA joint. JCI Insight 2020;5.
Lee AY, Körner H. CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis. Immunol Cell Biol 2014;92:354-8.
Yang Z, Shen Y, Oishi H, Matteson EL, Tian L, Goronzy JJ, et al. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci Transl Med 2016;8:331ra38.
Hidalgo A, Chilvers ER, Summers C, Koenderman L. The neutrophil life cycle. Trends Immuno 2019;40:584-97.
Van Delft MA, Huizinga TW. An overview of autoantibodies in rheumatoid arthritis. J Autoimmun 2020;110:102392.
Arumugam S, Jeyasekaran V, Sivasubramaniam J, Shanmugam P. Evaluation of the diagnostic utility of second generation anti-cyclic citrullinated antibodies and rheumatoid factor igm isotype in clinically suspected rheumatoid arthritis patients. J Clin Diagn Res 2019;13.
Dedmon LE. The genetics of rheumatoid arthritis. Rheumatology 2020;59:2661-70.
Ishigaki K, Sakaue S, Terao C, Luo Y, Sonehara K, Yamaguchi K, et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat Genet 2022;54:1640-51.
Abbasifard M, Imani D, Bagheri-Hosseinabadi Z. PTPN22 gene polymorphism and susceptibility to RA: updated systematic review and meta-analysis. J Gene Med 2020;22:e3204.
Fiorillo E, Orru V, Stanford SM, Liu Y, Salek M, Rapini N, et al. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem 2010;285:26506-18.
Akhtar M, Jamal T, Jamal H, Din JU, Jamal M, Arif M, et al. Identification of most damaging nsSNPs in human CCR6 gene: In silico analyses. Int J Immunogenet 2019;46:459-71.
Nanki T, Takada K, Komano Y, Morio T, Kanegane H, Nakajima A, et al. Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 2009;11:1-1.
Mousavi MJ, Shayesteh MR, Jamalzehi S, Alimohammadi R, Rahimi A, Aslani S, et al. Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: a systematic review and meta-analysis. J Res Med Sci 2021;26:22.
Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity 2017;46:183-96.
Lei C, Dongqing Z, Yeqing S, Oaks MK, Lishan C, Jianzhong J, et al. Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur J Hum Genet 2005;13:823-8.
Croft M, Siegel RM. Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases. Nat Rev Rheumatol 2017;13:217-33.
Kurreeman FA, Goulielmos GN, Alizadeh BZ, Rueda B, Houwing-Duistermaat J, Sanchez E, et al. The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases. Ann Rheum Dis 2010;69:696-9.
Cheng T, Sun X, Wu J, Wang M, Eisenberg RA, Chen Z. Increased serum levels of tumor necrosis factor receptor-associated factor 1 (TRAF1) correlate with disease activity and autoantibodies in rheumatoid arthritis. Clin Chim Acta 2016;462:103-6.
Rong H, He X, Wang L, Bai M, Jin T, Wang Y, et al. Association between IL1B polymorphisms and the risk of rheumatoid arthritis. Int Immunopharmacol 2020;83:106401.
Jahid M, Chawla D, Avasthi R, Ahmed RS. Association of polymorphic variants in IL1B gene with secretion of IL-1β protein and inflammatory markers in north Indian rheumatoid arthritis patients. Gene 2018 30;641:63-7.
Darwish RK, Ramadan DI, Mohy AM, Raafat HA, Abou Youssef HE, El-Kateb SM. Interleukin-1 β gene polymorphisms in Egyptian patients with rheumatoid arthritis. Comp Clin Path 2014;23:689-94.
Go E, Yoo SJ, Choi S, Sun P, Jung MK, Kwon S, et al. Peripheral blood from rheumatoid arthritis patients shows decreased Treg CD25 expression and reduced frequency of effector Treg subpopulation. Cells 2021;10:801.
Ross SH, Cantrell DA. Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol 2018;36:411-33.
Zhou X, Xing J, Tang X, Sheng X, Chi H, Zhan W. Interleukin-2 (IL-2) interacts with IL-2 receptor beta (IL-2Rβ): its potential to enhance the proliferation of CD4+ T lymphocytes in flounder (Paralichthys olivaceus). Front Immunol 2020;9;11:531785.
Massarenti L, Enevold C, Damgaard D, Ødum N, Garred P, Frisch M, et al. PADI4 polymorphisms confer risk of anti-CCP-positive rheumatoid arthritis in synergy with HLA-DRB1* 04 and smoking. Front Immunol 2021;18;12:707690.
Darrah E, Andrade F. Rheumatoid arthritis and citrullination. Curr Opin Rheumatol 2018;30:72.
Teo CY, Tejo BA, Leow AT, Salleh AB, Abdul Rahman MB. Novel furan-containing peptide-based inhibitors of protein arginine deiminase type IV (PAD4). Chem Biol Drug Des 2017;90:1134-46.
Michou L, Lasbleiz S, Rat AC, Migliorini P, Balsa A, Westhovens R, et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci 2007; 104:1649-54.
Cheng P, Zhang Y, Huang H, Zhang W, Yang Q, Guo F, et al. Association between CCR6 and rheumatoid arthritis: a meta-analysis. Int J Clin Exp Med 2015;8:5388.
Cheng T, Wu J, Xu Y, Liu C, Zhang H, Wang M. CD40/TRAF1 decreases synovial cell apoptosis in patients with rheumatoid arthritis through JNK/NF-κB pathway. J Bone Miner Metab 2022;40:819-28.
Dayer JM, Oliviero F, Punzi L. A brief history of IL-1 and IL-1 Ra in rheumatology. Front Pharmacol 2017;8:293.
Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009;21:279.
Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 2006;8:1-5.
Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004;50:72-7.
Edwards CJ, Cooper C. Early environmental factors and rheumatoid arthritis. Clin Exp Immunol 2006;143:1-5.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
